# Nirogacestat in Ovarian Granulosa Cell Tumors

> clinical trial · VERIFIED · 2026-08-25

Status: COMPLETED · Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany · Condition: Ovarian Granulosa-Stromal Tumor

- Company: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05348356

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.